Skip to main content

Blickenstaff Kim D's Form 4 filing

Tandem Diabetes Care Inc (TNDM) · filed May 19, 2022

Accession no.
0001438133-22-000087
Filed
May 19, 2022
Trade date
May 17-18, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $999.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Blickenstaff Kim DCIK 0001238913Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 17, 2022Common StockMOption exerciseAcquired+6,560$9.00+$59,0408,452Direct
May 18, 2022Common StockMOption exerciseAcquired+2,205$0.00$010,657Direct
May 17, 2022Common StockMOption exerciseAcquired+13,562$73.73+$999,926.26215,952Indirect
May 17, 2022Common StockSSaleDisposed−10,762$92.91−$999,897.42205,190Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 17, 2022Common StockMOption exerciseAcquired+6,560$9.00+$59,0400Direct
May 17, 2022Common StockMOption exerciseAcquired+13,562$73.73+$999,926.260Indirect
May 18, 2022Common StockMOption exerciseAcquired+2,205$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)